Ramesh K. Ramanathan - Researcher Profile

Publications

2 shown

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff , Thomas J. Ervin , Francis P. Arena +20 more

In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but...

2013 New England Journal of Medicine 6383 citations

Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Daniel D. Von Hoff , Ramesh K. Ramanathan , Mitesh J. Borad +13 more

Purpose The trial objectives were to identify the maximum-tolerated dose (MTD) of first-line gemcitabine plus nab-paclitaxel in metastatic pancreatic adenocarcinoma and to provi...

2011 Journal of Clinical Oncology 1034 citations

Frequent Co-Authors

Daniel D. Von Hoff

The University of Texas Health Science Center at San Antonio

Thomas J. Ervin

Florida Cancer Specialists & Research Institute

Francis P. Arena

Researcher Info

h-index: 2
Publications: 2
Citations: 7,417
Institution: Translational Genomics Research Institute

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.